Hashimoto’s thyroiditis does tend to get worse over time, though the pace varies widely from person to person. The core process is a slow immune attack on the thyroid gland that gradually destroys its ability to produce hormones. For many people, this means a steady drift from normal thyroid function into mild (subclinical) hypothyroidism, and eventually into full-blown hypothyroidism that requires lifelong medication. But aging also changes how the disease shows up, how it’s monitored, and how it’s treated.
What Happens to the Thyroid Over Time
Hashimoto’s is driven by immune cells, particularly a type of white blood cell called T cells, that infiltrate the thyroid gland and slowly destroy its hormone-producing tissue. Over years and decades, healthy thyroid tissue gets replaced by scar tissue (fibrosis), and the gland gradually shrinks. This process doesn’t happen overnight. It can unfold over 10, 20, or even 30 years, which is why many people with Hashimoto’s go years feeling fine before symptoms appear.
The progression follows a somewhat predictable pattern. Among people who start with subclinical hypothyroidism (where the thyroid is struggling but still keeping up), roughly 31% eventually progress to overt hypothyroidism, meaning the gland can no longer compensate. About 25% stay in the subclinical stage indefinitely. And interestingly, around 41% of people with early subclinical disease see their thyroid function spontaneously return to normal, at least temporarily. So while the overall trajectory of Hashimoto’s points toward worsening, it’s not a guaranteed downhill slide for everyone.
Among people who start with completely normal thyroid function despite having Hashimoto’s antibodies, about 31% develop subclinical hypothyroidism and 12% progress all the way to overt hypothyroidism over time.
How Antibody Levels Change With Age
Thyroid antibodies (specifically TPO antibodies, the hallmark of Hashimoto’s) follow a pattern that might surprise you. An 18-year population study out of Tehran tracked antibody levels over time and found that the prevalence of TPO antibody positivity rose from about 12% to 16% in the general population over that period. But the trend wasn’t uniform across age groups.
People under 40 and those between 40 and 60 showed clear increases in antibody positivity over time. However, people over 60 actually showed stable or slightly declining rates, going from 15% to about 14.4%. Younger age was actually associated with a higher risk of developing new antibody positivity, suggesting the autoimmune process tends to ignite earlier in life rather than later.
For individuals already tracking their antibody levels, the long-term data revealed four distinct patterns. The vast majority of people (81%) maintained stable, low antibody levels throughout the study. About 13% had consistently high levels that stayed elevated. A small group (3%) saw their antibodies rise significantly over time, while another small group (2.4%) experienced a marked decrease. Women were about 60% more likely than men to develop antibody positivity, and having an already-elevated TSH more than doubled the risk.
Why Symptoms Look Different in Older Adults
One of the trickiest aspects of Hashimoto’s in older adults is that it becomes harder to recognize. A study comparing hypothyroid patients over 70 with younger patients (average age around 41) found that older adults presented with significantly fewer symptoms. Younger patients averaged about 9 recognizable signs of hypothyroidism, while older patients averaged only about 7. Only two symptoms appeared in more than half of elderly patients: fatigue and weakness.
Several classic hypothyroid symptoms, including feeling cold, tingling or numbness in the hands and feet, weight gain, and muscle cramps, were significantly less common in older adults. This doesn’t mean the disease is milder. It means the symptoms overlap heavily with what many people chalk up to “just getting older,” making the condition easy to miss. Fatigue, constipation, dry skin, and mental sluggishness can all be dismissed as normal aging when they’re actually signs of an underactive thyroid. This is a major reason why routine thyroid testing matters more as you age, not less.
TSH Targets Shift With Age
Your TSH level is the primary number used to assess thyroid function, and what counts as “normal” actually changes as you get older. Both the American Thyroid Association and the European Thyroid Association recommend using age-specific reference ranges, particularly for people over 60. The standard upper limit of TSH for younger adults is typically around 4.0 to 4.5 mIU/L, but guidelines from the French Society of Endocrinology suggest a practical formula for older adults: divide your age (by decade) by 10. So a TSH of 7 mIU/L might be perfectly acceptable for someone in their 70s, and 8 mIU/L for someone over 80.
This matters because it changes the threshold for treatment. A slightly elevated TSH in someone who is 75 doesn’t carry the same significance as the same number in someone who is 35. Overtreating an older adult with thyroid hormone replacement can cause real harm, including heart rhythm problems and accelerated bone loss. The goal shifts from optimizing numbers to avoiding both undertreated hypothyroidism and the risks of overreplacement.
How Treatment Changes for Older Adults
If you’ve been on thyroid medication for years, your dose will likely need adjustment as you age. Research from the Baltimore Longitudinal Study of Aging found that older adults need roughly one-third less medication per kilogram of body weight compared to younger adults. Where younger patients typically require around 1.6 micrograms per kilogram, older adults averaged closer to 1.1 micrograms per kilogram of actual body weight.
The reason is partly metabolic. As you age, your lean body mass decreases, your metabolism slows, and your body clears thyroid hormone more slowly. On top of that, older adults are more vulnerable to the cardiac effects of excess thyroid hormone, so doctors typically start with lower doses and increase gradually. If you’ve been on the same dose for a decade, your needs may have quietly shifted, and a check-in with your provider about whether your dose still fits is worthwhile.
For people with obesity, dosing gets even more nuanced. The Baltimore study found that obese older adults needed a lower dose per kilogram of actual body weight compared to non-obese individuals, though when calculated using ideal body weight the numbers were similar. This reinforces that dosing isn’t as simple as multiplying a number by your scale weight.
The Cardiovascular Question
One of the most common concerns about long-standing hypothyroidism is heart health. Untreated or poorly managed hypothyroidism can raise cholesterol levels and contribute to cardiovascular risk. However, the data on whether subclinical hypothyroidism specifically increases heart disease risk in older adults is surprisingly reassuring. A large study of older adults (the Cardiovascular Health Study) found that subclinical hypothyroidism was associated with only a 7% increase in the risk of coronary heart disease, a difference that wasn’t statistically significant.
This doesn’t mean you should ignore your thyroid levels. Overt hypothyroidism with significantly elevated TSH still carries real cardiovascular consequences, including elevated cholesterol, increased arterial stiffness, and a higher risk of heart failure. The takeaway is that mild, well-monitored thyroid dysfunction in an older adult is not the emergency it might feel like, while significantly uncontrolled disease still warrants attention.
What Actually Drives Worsening
Age itself is only one factor in how Hashimoto’s progresses. Several things can accelerate or slow the course of the disease. Higher baseline TSH levels are one of the strongest predictors. The Tehran study found that having a TSH of 5 mIU/L or higher was associated with a 2.7 times greater risk of developing new antibody positivity, suggesting that even mild thyroid stress can feed a worsening cycle.
Sex plays a role too. Women are more likely to develop the condition and more likely to see it progress. Smoking, excess iodine intake, certain medications, and other autoimmune conditions can also push the disease forward. On the other hand, some people experience long periods of stability, and a meaningful minority see spontaneous improvement in thyroid function, particularly in the earlier stages of disease.
The bottom line is that Hashimoto’s generally trends toward more thyroid damage and greater reliance on medication over time, but the speed of that progression varies enormously. Regular monitoring, age-appropriate TSH targets, and dose adjustments as your body changes are the practical tools that keep the disease well managed across decades.